Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

Delayed Data
As of Jan 21
 -1.59 / -9.35%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 16 analysts offering 12-month price forecasts for Intercept Pharmaceuticals Inc have a median target of 25.50, with a high estimate of 82.00 and a low estimate of 11.00. The median estimate represents a +65.48% increase from the last price of 15.41.

Analyst Recommendations

The current consensus among 17 polled investment analysts is to Hold stock in Intercept Pharmaceuticals Inc. This rating has held steady since January, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Feb 24

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -846.55%
Growthannually 68.56%


Growthquarterly -0.47%
Growthannually 16.24%
Key to the earnings and sales forecast charts.